Prospects for Covid-19 vaccine companies diminish


Strict procedures: With the exception of the big-players, there have been no further approvals given by the health regulators for other companies to distribute or make vaccines in Malaysia.

THE excitement seen some two years ago over the potential of companies profiting from Covid-19 vaccine-related activities appears to have died down.

This comes at a time when people have generally tried to put the Covid-19 pandemic firmly behind them.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 48
Cxense type: NA
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Business News

Tiong Nam sees higher demand for for logistics, warehousing services in FY23
Leong Hup returns to the black, 3Q net profit at RM67.31mil
Malakoff 3Q net profit jumps 53.4% to RM66.5mil
IHH 3Q profit falls to RM252mil on exceptional items, financial reporting adjustments
Ringgit reverses gains against US dollar on profit-taking
Boustead net profit jumps to RM99.6mil in 3Q
Press Metal 3Q net profit grows 11.5% to RM315.8mil
Genting Malaysia misses Macau licence
Celcom 3Q22 Patami up 65.3% at RM856mil
Kerjaya Prospek's construction segment to drive revenue growth

Others Also Read